Depression is often thought of as a disorder of mood characterized by sadness, low energy, and loss of interest. However, many patients’ concerns extend past questions of current health and into the future. They wonder, “Does Depression cause memory issues in the long-term? Is it a risk factor for dementia?”
Research has revealed that Depression carries more than psychological impacts; it may also affect a patient’s long-term neurological health. “Depression and Risk for Alzheimer Disease,” a review and meta-analysis published by Ownby et al. in May 2006, sought to identify whether Depression is a risk factor for Alzheimer disease (AD).
Key Takeaways
- The researchers’ goal was to determine whether Depression is a risk factor for developing AD later in life. They assessed data from over 100,000 patients in order to reach their conclusions.
- The research identified that those diagnosed with Depression are approximately twice as likely to develop AD.
- Further research is necessary in order to determine if there is a genetic link between Depression and AD.
- Depression treatment is not simply a matter of treating mood-based symptoms; it also requires treating long-term brain health.
- Alternative, brain-based treatments like TMS and Spravato offer excellent solutions for Depression patients who have not found relief from antidepressants.
Study Overview
Ownby and colleagues sought to answer a critical question: does Depression increase the risk of developing AD? In order to reach a conclusion, they conducted a systematic review, meta-analysis, and metaregression analysis of 20 independent studies, cumulatively sampling over 100,000 participants. Those sampled came from both community and clinical cohorts.
Although the reviewed studies differed in Depression assessment methods, Alzheimer diagnostic criteria, and follow-up durations, the researchers’ statistical techniques were able to identify overarching trends.
Findings from the Research
The central finding was clear: Depression is associated with increased risk of AD. The meta-analysis indicated that those with a history of Depression were approximately twice as likely to develop AD as those without Depression, and having a longer interval between Depression and AD diagnoses was linked to a higher risk of developing the latter. This suggests that Depression functions as an independent risk factor as opposed to a prodrome of AD.
It is worth noting that all of the referenced studies were observational, their methodologies varied, and causality between Depression and AD was not definitively established. Even still, the aforementioned findings were consistent across 19 of the 20 studies, strengthening the validity of the research team’s conclusions.
Does Depression Cause Memory Issues? Possible Reasons for the Link
The study’s data could not provide a definite reason for the link between the two diseases, but the researchers did explore several possible explanations for the observed relationship. There may be a genetic link between Depression and AD, particularly as it regards the ε4 allele, which is a known risk factor for the latter. However, while other researchers have explored whether there is a connection between ε4 and depressive symptoms, their results were inconclusive.
Vascular disease may also play a role in the two conditions. According to Ownby et al., “AD and [Depression] may share risk factors for vascular disease” (2006). Similarly, proinflammatory cytokines, which are proteins that amplify inflammation in the body, could be related. They have been linked to Depression and vascular disease, and they might impact cognitive status.
Clinical Implications
The researchers’ findings reinforce that Depression is not a temporary emotional state. It can affect long-term brain health and increase risk for serious neurological disease.
As such, treating Depression is linked to more than improving mental and emotional health; it has the potential to promote long-term health. Patients may ask, “Does Depression cause memory issues?” but there are other imperative questions at play: which treatments are available to Depression patients? And what should they turn to when traditional treatments do not provide relief?
Limitations of Traditional Depression Treatments
Antidepressants and psychotherapy can help many patients, but they have their limitations. These treatments may not fully address brain circuit dysfunction, nor the neurobiological changes associated with Depression.
Why Brain-Based Treatments May Be Especially Important
Given the link between Depression and neurodegeneration, treatments that directly target brain function may offer important advantages. Alternative, brain-based solutions can be especially important for patients who haven’t responded to medications and continue to experience depressive symptoms.
Transcranial Magnetic Stimulation (TMS)
TMS is a non-invasive treatment that:
- Stimulates specific brain regions involved in mood regulation
- Enhances neuroplasticity
- Improves functional connectivity
By improving brain function and potentially promoting neural resilience, TMS may provide benefits that extend past symptom relief.
Spravato (Esketamine)
Spravato is a rapid-acting treatment that:
- Targets the glutamate system
- Promotes synaptic growth and plasticity
Spravato provides rapid symptom relief, and it is especially helpful for those with treatment-resistant Depression due to its impacts on brain connectivity and function.
Mid City TMS Offers Brain-Based Depression Treatments
Does Depression cause memory issues, particularly for long-term brain health? Ownby and colleagues’ meta-analysis provides compelling evidence that, yes, Depression is associated with a statistically significant increased risk of developing AD. If you struggle with Depression, choosing effective, targeted, and biologically informed interventions has the potential to improve your long-term health.
If you have not had success with previous antidepressant treatments, Mid City TMS offers TMS and Spravato to address the underlying biology of Depression. At our New York City office, it is our goal to help patients achieve meaningful recoveries.
To learn more about our services, please contact us online or call us at 212-517-1867. We look forward to working with you.
Sources
- Ownby, Raymond L., et al. “Depression and Risk for Alzheimer Disease: Systematic Review, Meta-Analysis, and Metaregression Analysis.” Archives of General Psychiatry, vol. 63, no. 5, May 2006, pp. 530–38, doi:10.1001/archpsyc.63.5.530.